Pulmonary Hypertension: A Cancerous Proliferative Vascular Disorder?

All credit to Prof. Serge Adnot, Professor of Physiology at INSERM, Creteil, France

Part 3

Additional key-words: malignancy,clinical trials,serotonin

About the author

France

France

Authors: Wessler BS, Paulus J, Lundquist CM, Ajlan M, Natto Z, Janes WA, Jethmalani N, Raman G, Lutz JS, Kent DM Source: Diagn Progn Res

Authors: Bosisio M, Pâquet M, Bois K, Rosen NO, Bergeron S Source: J Sex Res

Authors: Ribeiro IB, Ruel M Source: Innovations (Phila)

Authors: Zaghloul SG, Wahab EA, Seleem WM, Hanafy AS, Gomaa AF, Lakouz K, Amin AI Source: Drug Discov Ther

Authors: Leusink P, Steinmann R, Makker M, Lucassen PL, Teunissen D, Lagro-Janssen AL, Laan ET Source: Fam Pract

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI